
Opinion|Videos|November 27, 2025
Barriers to Adoption of SC Therapies
Panelists discuss how overcoming logistical and perceptual barriers will drive wider adoption of SC therapies in NSCLC.
Advertisement
Episodes in this series

Panelists discuss how barriers such as provider hesitancy, reimbursement concerns, and logistical complexities slow the adoption of subcutaneous (SC) therapies. They propose strategies including education, workflow redesign, and advocacy to increase confidence in SC delivery. The discussion emphasizes that as data accumulate and experience grows, institutional and cultural shifts will further integrate SC therapy
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Trump Childhood Vaccine Order: What It Means for Parents and Payers
2
CMS Final Rule Ends Federal Medicaid, CHIP Funding for Youth Gender-Affirming Care
3
Payer Barriers and Anatomic Urgency in Vitiligo Treatment
4
Classifying Vitiligo Severity Beyond Body Surface Area
5




